ELEscarlata López

Escarlata López

*This is an algorithmically generated author record based on publicly available information.

Escarlata López has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Darlene Rodrigues

    Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228 4050-313, Porto, Portugal; Center for Health Technology and Services Research-AgeingC/RISE - Health Research Network, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal

    3 shared publications
  • Laetitia Teixeira

    Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal

    3 shared publications
  • Paulo Almeida

    Serviço de Medicina Interna. Unidade Local de Saúde de São João. Porto

    2 shared publications
  • Daniela Gonsalves

    GenesisCare en Madrid, Hospital San Francisco de Asís, Madrid, Spain

    1 shared publication

Latest Publications

  • Open Access

    An evaluation of Portuguese radiation oncologists knowledge and practice in relation to geriatric oncology

    by Edna Darlene Rodrigues Pinto, Paulo Almeida, Escarlata López, Laetitia Teixeira

    Introduction: Cancer is a major health concern in Portugal, especially among older adults, who represent nearly half of new cases. Radiation therapy (RT) is crucial in their treatment, emphasizing the need for improved education in geriatric oncology for radiation oncologists (RO). Methods: A pretested 22-item online survey on RO’s geriatric oncology knowledge was disseminated. Results: The analysis involved 52 respondents, including 13 residents (25%) and 39 consultants (75%); RO were asked to specify the age threshold they considered to define an older cancer patient. Their responses were as follows: 60 years (n = 2, 3·8%), 65 years (n = 7, 13·5%), 68 years (n = 1, 1·9%), 70 years (n = 29, 55·8%), 75 years (n = 10, 19·2%) and 80 years (n = 2, 3·8%). Forty-six respondents (88·5%) acknowledged an observed increase in the number of older cancer patients in RT departments. Twenty-nine participants (55·8%) reported that age was considered either most of the time or always in clinical decisions. Regarding frailty screening, it was performed by 15 participants (28·8%), while four participants (7·7%) stated that frailty was assessed during comprehensive geriatric assessment in another department. Of those implementing screening tools, nine (17·3%) utilized the G8 tool, and two respondents (3·8%) employed the Triage Risk Screening Tool. Most respondents reported a lack of awareness regarding specific guidelines for older cancer patients, and 98·1% expressed the need for enhanced training in geriatric oncology. Conclusion: The study highlights a critical need for improved training in geriatric oncology among RO professionals. Furthermore, the findings underscore the imperative for treatment decisions to reflect an understanding beyond chronological age, emphasizing the necessity of addressing this knowledge gap in clinical practice.

  • Open Access

    The Future Needs of External Beam Radiotherapy in Portugal Until 2040

    by E.D. Rodrigues, P. Almeida, E. López Ramírez, L. Teixeira

  • Frailty—the missing constraint in radiotherapy treatment planning for older adults

    by Edna Darlene Rodrigues, Daniela Gonsalves, Laetitia Teixeira, Escarlata López

    Current demographic changes translate into an increased frequency of cancer in older adults. Available data show that about 45–55% of the new cancer patients will need RT treatments, with an expected increase of 20–30% in the future. To provide the best cancer care it is mandatory to assess frailty, offer appropriate curative treatments to patients and personalise them for the frail. Based on published data, the median prevalence of frailty in older population is about 42%. Recently, the free radical theory of frailty has been proposed stating that oxidative damage is more prevalent in frail patients. In parallel, RT is one of the most frequent cancer treatments offered to older adults and is a source of external free radicals. RT dose constraints correlate with toxicity rates, so we open the question whether frailty should be considered when defining these constraints. Thus, for this paper, we will highlight the importance of frailty evaluation for RT treatment decisions and outcomes.